Immune to Cancer: The CRI Blog
-
ASCO 2023 Preview — Partnering with Patients: The Cornerstone of Cancer Care and Research
This weekend, the highly anticipated 2023 annual meeting of the American Society of Clinical Oncologists (ASCO) takes… -
<strong>Exploring the Future of Cancer Immunotherapy, with Dr. Nina Bhardwaj</strong>
The field of cancer immunotherapy has achieved great progress already in 2023. With each passing day, new… -
<strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>
More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR… -
<strong>E. John Wherry, PhD, Receives 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology</strong>
E. John Wherry, PhD — the director of the Institute for Immunology, chair of the Department of… -
AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine
From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell… -
<strong>A Conversation with CRI ImmunoAdvocate Karen Peterson</strong>
Karen Peterson shares her journey from an immunotherapy clinical trial to patient advocate working to improve clinical… -
Love in the Lab: Valentine’s Day with the Doctors Delgoffe
CRI celebrates Valentine’s Day with immunologists Abby and Greg Delgoffe At first glance, one might not link… -
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
In 2017, I was diagnosed with stage four triple-negative breast cancer (TNBC), one of the most aggressive… -
Celebrating Seven Decades of CRI Discovery in Cancer Immunotherapy
On January 27, 1953, the Cancer Research Institute’s founders, Helen Coley Nauts and Oliver R. Grace Sr.,…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.